Neuronal thread protein regulation and interaction with microtubule-associated proteins in SH-Sy5y neuronal cells

scientific article published in December 2003

Neuronal thread protein regulation and interaction with microtubule-associated proteins in SH-Sy5y neuronal cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00018-003-3305-3
P8608Fatcat IDrelease_5gxlbbjfjvcxnfczyal6csrdha
P698PubMed publication ID14685691

P50authorGuo-jun ChenQ43183546
P2093author name stringS M de la Monte
J R Wands
E Rivera
P2860cites workA randomized trial of rosuvastatin in the prevention of venous thromboembolismQ37262627
The JUPITER trial: results, controversies, and implications for preventionQ38469911
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trialQ38473723
Is hsCRP Back on Board? Implications from the JUPITER TrialQ38474718
Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.Q40442526
C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern GermanyQ40524614
C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort StudyQ40828366
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary eventsQ43656468
Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United StatesQ44298314
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaQ58230388
Genetic Loci associated with C-reactive protein levels and risk of coronary heart diseaseQ24649709
Use of multiple biomarkers to improve the prediction of death from cardiovascular causesQ28280099
Inflammation in atherosclerosisQ29547428
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinQ29547752
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart AssociationQ30434464
Genetic variation in Fc gamma receptor IIa and risk of coronary heart disease: negative results from two large independent populationsQ33456200
From here to JUPITER: identifying new patients for statin therapy using data from the 1999-2004 National Health and Nutrition Examination SurveyQ33520621
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart diseaseQ34311841
National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular diseaseQ34602361
Genetically elevated C-reactive protein and ischemic vascular diseaseQ34868720
The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelinesQ34907937
Novel and conventional biomarkers for prediction of incident cardiovascular events in the communityQ34960396
C-reactive protein: risk marker or mediator in atherothrombosis?Q35775733
Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive proteinQ36027468
Biomarkers of atherosclerotic plaque instability and ruptureQ36643429
The use of high-sensitivity assays for C-reactive protein in clinical practiceQ37090943
P433issue12
P407language of work or nameEnglishQ1860
P304page(s)2679-2691
P577publication date2003-12-01
P1433published inCellular and Molecular Life SciencesQ5058352
P1476titleNeuronal thread protein regulation and interaction with microtubule-associated proteins in SH-Sy5y neuronal cells
P478volume60

Reverse relations

cites work (P2860)
Q95277354Aerobic Glycolysis in the Retina: Functional Roles of Pyruvate Kinase Isoforms
Q34020000Alzheimer's disease is type 3 diabetes-evidence reviewed
Q28259585Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease
Q35997881Brain metabolic dysfunction at the core of Alzheimer's disease
Q35997824Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease
Q38561865Linking insulin with Alzheimer's disease: emergence as type III diabetes
Q47113718Mechanisms linking brain insulin resistance to Alzheimer's disease
Q58805850Metabolic Syndrome Exacerbates the Recognition Memory Impairment and Oxidative-Inflammatory Response in Rats with an Intrahippocampal Injection of Amyloid Beta 1-42
Q39195275Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease
Q58795095Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes?
Q37035260Practical utility of urinary assay in the diagnosis of Alzheimer's disease: AlzheimAlert
Q35040395Role of central nervous system insulin resistance in fetal alcohol spectrum disorders
Q58788781The association between urinary Alzheimer-associated neuronal thread protein and cognitive impairment in late-life depression: a controlled pilot study
Q57791805Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications
Q34432135Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review
Q42363345Urine AD7c-NTP Predicts Amyloid Deposition and Symptom of Agitation in Patients with Alzheimer's Disease and Mild Cognitive Impairment

Search more.